Table of Contents
Catheter Precision, Inc., a leading innovator in the medical device sector, has appointed Philip Anderson as its new Chief Financial Officer. This strategic move comes as the company continues to expand its footprint in the cardiac electrophysiology market, with Anderson bringing a wealth of experience to the role.
Key Takeaways
- Philip Anderson joins Catheter Precision as Chief Financial Officer.
- Margrit Thomassen transitions to the role of Controller.
- Anderson has extensive experience in executive management and investment banking.
- The company is focused on cardiac electrophysiology products with promising growth potential.
New Leadership at Catheter Precision
On January 7, 2025, Catheter Precision, Inc. announced the appointment of Philip Anderson as its new Chief Financial Officer. Anderson succeeds Margrit Thomassen, who has served as the Interim CFO and will now take on the role of Controller.
David Jenkins, the CEO of Catheter Precision, expressed his enthusiasm about Anderson’s appointment, stating, “After some time of searching for the right fit, we are happy to have concluded our search with Phil Anderson joining the team. His background includes executive management across a variety of industries, managing hedge funds at the partner level, and an early stint in investment banking. We are excited that he is joining the team immediately.”
Anderson’s Vision for the Future
In his first comments as CFO, Anderson shared his excitement about joining Catheter Precision. He highlighted several factors that influenced his decision:
- Market Potential: The cardiac electrophysiology sector is experiencing significant growth, presenting ample opportunities for innovation and development.
- Strong Management Team: Anderson noted the impressive credentials of the current management team, including CEO David Jenkins and Marie-Claude Jacques, who has a robust background in sales and leadership within the industry.
- Product Development: The company is at a pivotal stage with two products entering the revenue cycle, backed by strong clinical evidence.
- Alignment of Skills: Anderson believes his expertise in finance and operations aligns perfectly with the company’s current needs.
Incentives for Anderson
As part of his employment agreement, Anderson received an inducement award of options to purchase 500,000 shares of Catheter Precision common stock. These options have an exercise price of $0.53 per share, vest monthly over three years, and have a term of 10 years. This incentive underscores the company’s commitment to aligning leadership interests with shareholder value.
About Catheter Precision
Catheter Precision, Inc. is a U.S.-based medical device company dedicated to improving the treatment of cardiac arrhythmias. The company focuses on developing innovative technologies for electrophysiology procedures by collaborating closely with healthcare professionals and continuously advancing its product offerings. With the recent leadership changes, Catheter Precision is poised to enhance its strategic initiatives and drive growth in the evolving medical landscape.
Sources
- Catheter Precision, Inc. Announces New Chief Financial Officer, Yahoo Finance.
